Federal Register of Legislation - Australian Government

Primary content

Poisons Standard Amendment No. 4 of 2011

Authoritative Version
  • - F2011L02057
  • No longer in force
Standards/Other as made
This instrument amends the Poisons Standard 2011.
Administered by: Health
Registered 12 Oct 2011
Tabling HistoryDate
Tabled HR13-Oct-2011
Tabled Senate13-Oct-2011
Date of repeal 19 Mar 2014
Repealed by Health (Spent and Redundant Instruments) Repeal Regulation 2014

 

 

 

 

 

 

POISONS STANDARD AMENDMENT No. 4 OF 2011

 

I, ANTHONY GILL, a delegate of the Secretary to the Department of Health and Ageing for the purposes of paragraph 52D(2)(a) of the Therapeutic Goods Act 1989 (the Act) and acting in accordance with the Secretary’s power under that paragraph of the Act, hereby amend the Poisons Standard 2011 in the manner set out in Schedule 1.

 

The amendments to the Poisons Standard 2011 as set out in Schedule 1 are taken to have commenced on 1 September 2011.

 

 

 

 

(signed by)

ANTHONY GILL

Delegate of the Secretary to the Department of Health and Ageing

 

 

Dated this 27th day of September 2011

 

 

 

 

 

 

 

 

 

 

 

 

 

Schedule 1-Amendments to the Poisons Standard 2011

 

 


 

 

 

 

 

STANDARD

FOR THE

UNIFORM SCHEDULING

OF

MEDICINES AND POISONS

 

No. 2

 

 

 

AMENDMENT No. 2

 


Effective Date – 1 September 2011


© Commonwealth of Australia 2011

 

Online ISBN: 978-1-74241-586-4

 

This work is copyright. You may download, display, print and reproduce the whole or part of this work in unaltered form for your own personal use or, if you are part of an organisation, for internal use within your organisation, but only if you or your organisation do not use the reproduction for any commercial purpose and retain this copyright notice and all disclaimer notices as part of that reproduction. Apart from rights to use as permitted by the Copyright Act 1968 or allowed by this copyright notice, all other rights are reserved and you are not allowed to reproduce the whole or any part of this work in any way (electronic or otherwise) without first being given the specific written permission from the Commonwealth to do so. Requests and inquiries concerning reproduction and rights are to be sent to the Communications Branch, Department of Health and Ageing, GPO Box 9848, Canberra ACT 2601, or via e-mail to copyright@health.gov.au.

 

Published by the Australian Government under the Therapeutic Goods Act 1989.

 

Publication Approval Number: D0577

 

 

 

 

 

 

 

 


The amendments listed in this document are a result of a decision made by the Secretary of the Department of Health and Ageing or the Secretary’s delegate.  The basis of these amendments can be found in the ‘Reasons for delegate’s final decisions’, which can be accessed from the scheduling website:

 

www.tga.gov.au/industry/scheduling-decisions-final.htm

 

Further inquiries should be directed to:

   The Secretary

   Medicines and Poisons Scheduling Secretariat

   Office of Chemical Safety (MDP 88)

   GPO Box 9848

   CANBERRA  ACT  2601

 

Or by email:  SMP@health.gov.au

 

Media Liaison Unit

Australian Government Department of Health and Ageing


Part A – AMENDMENTS TO THE SUSMP No. 2

Amendments to the Standard for the Uniform Scheduling of Medicines and Poisons

 

The Secretary of the Department of Health and Ageing directs that the amendments below be applied to the Standard for the Uniform Scheduling of Medicines and Poisons No. 2 (SUSMP 2) and recommends that these amendments be adopted by the States and Territories from 1 September 2011.

 

Part 4 – The Schedules

SCHEDULE 2 – AMENDMENT

 

FEXOFENADINE – Amend entry to read:

FEXOFENADINE in preparations for oral use except in preparations for the treatment of seasonal allergic rhinitis in adults and children 12 years of age and over when:

(a)     in a primary pack containing 10 dosage units or less and not more than 5 days supply; and

(b)     labelled with a recommended daily dose not exceeding 120 mg of fexofenadine.

 

SCHEDULE 4 – AMENDMENT

 

FEXOFENADINE – Amend entry to read:

FEXOFENADINE except:

(a)     when included in Schedule 2; or

(b)     in preparations for the treatment of seasonal allergic rhinitis in adults and children 12 years of age and over when:

(i)           in a primary pack containing 10 dosage units or less and not more than 5 days supply; and

(ii)          labelled with a recommended daily dose not exceeding 120 mg of fexofenadine.